MEI Pharma pushes back on activist investors after failed mergernews2023-09-29T13:36:38+00:00September 29th, 2023|Endpoints News|
Adlai Nortye prices Nasdaq IPO, raises $97.5Mnews2023-09-29T11:46:27+00:00September 29th, 2023|Endpoints News|
Structure Therapeutics’ oral GLP-1 shows 5.4% weight loss after 28 days of treatmentnews2023-09-29T11:30:14+00:00September 29th, 2023|Endpoints News|
Scoop: Altesa BioSciences raises $35M for antivirals, recruits Moncef Slaoui to boardnews2023-09-29T11:16:44+00:00September 29th, 2023|Endpoints News|
Exclusive: Former Genentech duo reunites to push Sonoma into the clinic; Ex-Magenta commercial chief heads to Editasnews2023-09-29T11:00:35+00:00September 29th, 2023|Endpoints News|
PTC cuts 25% of its workforce to save money amid big company revamp news2023-09-29T10:53:22+00:00September 29th, 2023|Endpoints News|
FDA lifts clinical hold on EryDel’s rare disease product ahead of Quince buyout closenews2023-09-29T09:53:58+00:00September 29th, 2023|Endpoints News|
Cambridge startup Thymmune lands $37M from Biden’s ARPA-H for thymus-rejuvenating therapiesnews2023-09-29T08:34:36+00:00September 29th, 2023|Endpoints News|
FDA approves major depressive drug after rejecting it multiple times in 24-year saganews2023-09-28T19:33:41+00:00September 28th, 2023|Endpoints News|
FDA turns to Fresenius imports from EU to help with common cancer drug shortagenews2023-09-28T19:18:35+00:00September 28th, 2023|Endpoints News|
